Skip to main content

Advertisement

Log in

DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was to evaluate the role of polymorphisms in DNA repair genes as genetic indicators of susceptibility to familial and sporadic breast cancer. We analysed DNA samples from 285 breast cancer patients and 442 control subjects, for XRCC1 Arg399Gln, XPD Lys751Gln, RAD51 G135C and XRCC3 Thr241Met polymorphisms using PCR-RFLP. We observed that women carriers of XRCC1 399Gln genotypes and without family history of breast cancer have a protective effect concerning this disease (OR = 0.54 95% CI 0.35–0.84; p = 0.006). Furthermore, we found that carriers of XRCC3 241Met genotypes without FH have an increased susceptibility of breast cancer (OR = 2.21 95% CI 1.42–3.44; p < 0.001). Additionally, we verified an increased risk of breast cancer in women with FH and carrying RAD51 135C genotypes (OR = 2.17 95% CI 1.19–3.98; p = 0.012). Our results suggest XRCC1 Arg399Gln and XRCC3 Thr241Met DNA repair polymorphisms as important biomarkers to sporadic breast cancer susceptibility, as well as, RAD51 G135C polymorphism as a real risk modifier in familial breast cancer cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pinheiro PS, Tycznski JE, Bray F et al (2003) Cancer Incidence and mortality in Portugal. Eur J Cancer 39:2507–2520

    Article  PubMed  CAS  Google Scholar 

  2. Dumitrescu RG, Cotarla I (2005) Understanding breast cancer risk—where do we stand in 2005? J Cell Mol Med 9:208–221

    Article  PubMed  CAS  Google Scholar 

  3. Dapic V, Carvalho MA, Monteiro AN (2005) Breast cancer susceptibility and the DNA damage response. Cancer Control 12:127–136

    PubMed  Google Scholar 

  4. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689

    Article  PubMed  CAS  Google Scholar 

  5. DeBruin LS, Josephy PD (2002) Perspectives on the chemical etiology of breast cancer. Environ Health Perspect 110(Suppl 1):119–128

    PubMed  CAS  Google Scholar 

  6. Cavalieri E, Frenkel K, Liehr JG et al (2000) Estrogens as endogenous genotoxic agents—DNA adducts and mutations. J Natl Cancer Inst Monogr 27:75–93

    PubMed  CAS  Google Scholar 

  7. Johnson-Thompson MC, Guthrie J (2000) Ongoing research to identify environmental risk factors in breast carcinoma. Cancer 88:1224–1229

    Article  PubMed  CAS  Google Scholar 

  8. Jyothish B, Ankathil R, Chandini R et al (1998) DNA repair proficiency: a potential marker for identification of high risk members in breast cancer families. Cancer Lett 124:9–13

    Article  PubMed  CAS  Google Scholar 

  9. Helzlsouer KJ, Harris EL, Parshad R et al (1996) DNA repair proficiency: potential susceptiblity factor for breast cancer. J Natl Cancer Inst 88:754–755

    Article  PubMed  CAS  Google Scholar 

  10. Kuschel B, Auranen A, McBride S et al (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399–1407

    Article  PubMed  CAS  Google Scholar 

  11. Shen MR, Jones IM, Mohrenweiser H (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604–608

    PubMed  CAS  Google Scholar 

  12. Mohrenweiser HW, Xi T, Vazquez-Matias J et al (2002) Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev 11:1054–1064

    PubMed  CAS  Google Scholar 

  13. Pachkowski BF, Winkel S, Kubota Y et al (2006) XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res 66:2860–2868

    Article  PubMed  CAS  Google Scholar 

  14. Clarkson SG, Wood RD (2005) Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 4:1068–1074

    Article  CAS  Google Scholar 

  15. Matullo G, Palli D, Peluso M et al (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22:1437–1445

    Article  PubMed  CAS  Google Scholar 

  16. Izumi T, Wiederhold LR, Roy G et al (2003) Mammalian DNA base excision repair proteins: their interactions and role in repair of oxidative DNA damage. Toxicology 193:43–65

    Article  PubMed  CAS  Google Scholar 

  17. Hung RJ, Hall J, Brennan P, et al (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am J Epidemiol 162:925–942

    Article  PubMed  Google Scholar 

  18. Callebaut I, Mornon JP (1997) From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett 400:25–30

    Article  PubMed  CAS  Google Scholar 

  19. Friedberg EC (2001) How nucleotide excision repair protects against cancer. Nat Rev Cancer 1:22–33

    Article  PubMed  CAS  Google Scholar 

  20. Benhamou S, Sarasin A (2005) ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 161:1–14

    Article  PubMed  Google Scholar 

  21. Seker H, Butkiewicz D, Bowman ED, et al (2001) Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res 61:7430–7434

    PubMed  CAS  Google Scholar 

  22. Qiao Y, Spitz MR, Shen H et al (2002) Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 23:295–299

    Article  PubMed  CAS  Google Scholar 

  23. Au WW, Salama SA, Sierra-Torres CH (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111:1843–1850

    PubMed  CAS  Google Scholar 

  24. Coin F, Marinoni JC, Rodolfo C, et al (1998) Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat Genet 20:184–188

    Article  PubMed  CAS  Google Scholar 

  25. Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247–254

    Article  PubMed  CAS  Google Scholar 

  26. Jackson SP (2002) Sensing and repairing DNA double-strand breaks. Carcinogenesis 23:687–696

    Article  PubMed  CAS  Google Scholar 

  27. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium (1997) Lancet 349:1505–1510

    Google Scholar 

  28. Medeiros R, Vasconcelos A, Costa S et al (2004) Linkage of angiotensin I-converting enzyme gene insertion/deletion polymorphism to the progression of human prostate cancer. J Pathol 202:330–335

    Article  PubMed  CAS  Google Scholar 

  29. Craveiro R, Costa S, Pinto D et al (2004) TP73 alterations in cervical carcinoma. Cancer Genet Cytogenet 150:116–121

    Article  PubMed  CAS  Google Scholar 

  30. Pinto D, Vasconcelos A, Costa S et al (2004) HER2 polymorphism and breast cancer risk in Portugal. Eur J Cancer Prev 13:177–181

    Article  PubMed  CAS  Google Scholar 

  31. Santos AM, Sousa H, Pinto D, et al (2006) Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer. Eur J Cancer 42:958–963

    Article  PubMed  CAS  Google Scholar 

  32. Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411:366–374

    Article  PubMed  CAS  Google Scholar 

  33. Seedhouse C, Faulkner R, Ashraf N et al (2004) Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 10:2675–2680

    Article  PubMed  CAS  Google Scholar 

  34. Skjelbred CF, Saebo M, Wallin H, et al (2006) Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer 6:67

    Google Scholar 

  35. Lewis R (2001) Human genetics. McGraw-Hill, New York

    Google Scholar 

  36. Casson AG, Zheng Z, Evans SC et al (2005) Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 26:1536–1541

    Article  PubMed  CAS  Google Scholar 

  37. Nelson HH, Kelsey KT, Mott LA et al (2002) The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res 62:152–155

    PubMed  CAS  Google Scholar 

  38. Metsola K, Kataja V, Sillanpaa P et al (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res 7:R987–R997

    Article  PubMed  CAS  Google Scholar 

  39. Chacko P, Rajan B, Joseph T et al (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89:15–21

    Article  PubMed  CAS  Google Scholar 

  40. Duell EJ, Millikan RC, Pittman GS et al (2001) Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10:217–222

    PubMed  CAS  Google Scholar 

  41. Zhang Y, Newcomb PA, Egan KM et al (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15:353–358

    Article  PubMed  CAS  Google Scholar 

  42. Moullan N, Cox DG, Angele S et al (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12:1168–1174

    PubMed  CAS  Google Scholar 

  43. Brewster AM, Jorgensen TJ, Ruczinski I et al (2006) Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat 95:73–80

    Article  PubMed  CAS  Google Scholar 

  44. Dufloth RM, Costa S, Schmitt F et al (2005) DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genet Mol Res 4:771–782

    PubMed  CAS  Google Scholar 

  45. Figueiredo JC, Knight JA, Briollais L et al (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 13:583–591

    PubMed  CAS  Google Scholar 

  46. Bu D, Tomlinson G, Lewis CM, et al (2006) An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Res Treat doi: 10.1007/s10549-006-9210-3

  47. Au WW, Navasumrit P, Ruchirawat M (2004) Use of biomarkers to characterize functions of polymorphic DNA repair genotypes. Int J Hyg Environ Health 207:301–313

    Article  PubMed  CAS  Google Scholar 

  48. Qu T, Morii E, Oboki K et al (2005) Micronuclei in EM9 cells expressing polymorphic forms of human XRCC1. Cancer Lett 221:91–95

    Article  PubMed  CAS  Google Scholar 

  49. Yu Z, Chen J, Ford BN et al (1999) Human DNA repair systems: an overview. Environ Mol Mutagen 33:3–20

    Article  PubMed  CAS  Google Scholar 

  50. Weiss KM, Terwilliger JD (2000) How many diseases does it take to map a gene with SNPs? Nat Genet 26:151–157

    Article  PubMed  CAS  Google Scholar 

  51. Justenhoven C, Hamann U, Pesch B et al (2004) ERCC2 Genotypes and a corresponding haplotype are linked with breast cancer risk in a German population. Cancer Epidemiol Biomarkers Prev 13:2059–2064

    PubMed  CAS  Google Scholar 

  52. Shi Q, Wang LE, Bondy ML et al (2004) Reduced DNA repair of benzo(a)pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25:1695–1700

    Article  PubMed  CAS  Google Scholar 

  53. Terry MB, Gammon MD, Zhang FF et al (2004) Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 13:2053–2058

    PubMed  CAS  Google Scholar 

  54. Benhamou S, Sarasin A (2002) ERCC2/XPD gene polymorphisms and cancer risk. Mutagenesis 17:463–469

    Article  PubMed  CAS  Google Scholar 

  55. Levy-Lahad E, Lahad A, Eisenberg S et al (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98:3232–3236

    Article  PubMed  CAS  Google Scholar 

  56. Wang WW, Spurdle AB, Kolachana P et al (2001) A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 10:955–960

    PubMed  CAS  Google Scholar 

  57. Kadouri L, Kote-Jarai Z, Hubert A et al (2004) A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer 90:2002–2005

    Article  PubMed  CAS  Google Scholar 

  58. Duarte F, Cameselle-Teijeiro JF, Soares R et al (2002) Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia. Rev Clin Esp 202:259–263

    PubMed  CAS  Google Scholar 

  59. Gray NK (1998) Translational control by repressor proteins binding to the 5′UTR of mRNAs. Methods Mol Biol 77:379–397

    PubMed  CAS  Google Scholar 

  60. Webb PM, Hopper JL, Newman B et al (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:319–323

    Article  PubMed  CAS  Google Scholar 

  61. Lindh AR, Rafii S, Schultz N et al (2006) Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility. Hum Mol Genet 15:1217–1224

    Article  PubMed  CAS  Google Scholar 

  62. Han J, Hankinson SE, Ranu H et al (2004) Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the nurses’ health study. Carcinogenesis 25:189–195

    Article  PubMed  CAS  Google Scholar 

  63. Jacobsen NR, Nexo BA, Olsen A et al (2003) No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol Biomarkers Prev 12:584–585

    PubMed  CAS  Google Scholar 

  64. Smith TR, Levine EA, Perrier ND et al (2003) DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1200–1204

    PubMed  CAS  Google Scholar 

  65. Ladiges W, Wiley J, MacAuley A (2003) Polymorphisms in the DNA repair gene XRCC1 and age-related disease. Mech Ageing Dev 124:27–32

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank to Oncology and Surgical Department from S. João Hospital at Porto, to Pathology Departments of the different Hospitals involved. We would like to thank to Imunohemotherapy Department of S. Marcos Hospital at Braga and Dr. Mário João for their helpful assistance in the management of controls. We gratefully acknowledge funding of this work by the FLAD (Fundação Luso-Americana para o Desenvolvimento), by the Minister of Health of Portugal (Comissão de Fomento da Investigacão em Cuidados de Saúde: CFICS-226/01), Astra Zeneca Foundation and Calouste Gulbenkian Foundation. We also gratefully acknowledge for financial support of individual grant for Doctoral degree of the first author to Minister of Science, Technology and Superior Education-FCT (Fundação para a Ciência e Tecnologia: SFRH/BD/9758/2003).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fernando Schmitt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Costa, S., Pinto, D., Pereira, D. et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103, 209–217 (2007). https://doi.org/10.1007/s10549-006-9364-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9364-z

Keywords

Navigation